Recall Record

Munich, N/A, Germany

Brainlab AG recalls

15 recalls recorded since 2018, most recently on 10 February 2025. 4 are listed as ongoing. Status and classification are as published by the FDA.

Recalls15
Ongoing (FDA)4
Terminated or completed11
Class I (FDA)1

Ongoing Class II Medical devices

Recall started
10 February 2025
Reason
Under certain circumstances, it can occur that patient records from unrelated individuals are automatically merged into one patient record without user notification.
Distribution
Worldwide - US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-1392-2025

Ongoing Class II Medical devices

Recall started
2 March 2023
Reason
Risk of mechanical instability due to potential manufacturing error of the device
Distribution
Texas
Initiated
Voluntary: Firm initiated
Recall number
Z-1292-2023

Ongoing Class II Medical devices

Recall started
14 February 2023
Reason
Deep Inspiration Breath Hold (DIBH) functionality may not work as specified when based on a standard-workflow Treatment Template
Distribution
US Nationwide distribution in the states of AZ, AR, CA, CO, FL, GA. IL, IN, KY, LA, MS, MO, NJ, NY, NC, ND, OK, OR, PA, TN, TX, VA, and WA. There was no government/military distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-1259-2023

Ongoing Class II Medical devices

Recall started
25 February 2022
Reason
The yaw angle may be incorrect for CBCT positioning workflows using setup beams with Varian LINACs.
Distribution
Distribution was made to AZ, AR, CA, CO, FL, GA, IN, KY, MD, MS, MO, NJ, NY, NC, OK, OR, PA, TX, VA, and WA. There was no government or military distribution. Foreign distribution was made to Australia, Austria, Bahrain, Belgium, China, Denmark, France, Germany, Hong Kong, India, Ireland, Israel,
Initiated
Voluntary: Firm initiated
Recall number
Z-0733-2022

Terminated Class II Medical devices

Recall started
14 May 2021
Terminated
20 March 2023
Reason
Display of potential patient movement might be delayed to the user for high dose treatments.
Distribution
US Nationwide distribution in the states of AZ, AR, CA, FL, IN, NJ, NY, NC, OR, PA, and TX. There was no government/military distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-1846-2021

Terminated Class II Medical devices

Recall started
1 March 2021
Terminated
20 March 2023
Reason
In case of a failed automatic marker detection, a software error causes parts of the display to incorrectly behave as if the current patient position is within predefined tolerances and may allow the user to proceed to treatment despite potentially exceeding shift values.
Distribution
USA: (CA, NJ, AZ, AR, NY, IN, OR, NC), Australia, Austria, Belgium, Denmark, France, Germany, Hong Kong, Italy, Slovakia, Spain, Thailand, Turkey, United Kingdom, United Arab Emirates.
Initiated
Voluntary: Firm initiated
Recall number
Z-1185-2021

Terminated Class II Medical devices

Recall started
31 August 2020
Terminated
17 February 2021
Reason
Brainlab Ultrasound Navigation Software does not support the modification of the probe's image width.
Distribution
Worldwide distribution - US Nationwide distribution including in the states of Illinois, Massachusetts, Texas, California, Idaho, Missouri, Oregon, Connecticut and the countries of Australia, Austria, Belgium, Brazil, Canada, China, Curacao, Czech Republic, Egypt, Finland, France, Germany, Switzerla
Initiated
Voluntary: Firm initiated
Recall number
Z-0056-2021

Terminated Class II Medical devices

Recall started
20 August 2020
Terminated
13 May 2021
Reason
Holding force of the Positioning Arm can be reduced by prolonged non-use.
Distribution
USA: DC, OH, IL OUS: Bulgaria; France; Germany; United Kingdom
Initiated
Voluntary: Firm initiated
Recall number
Z-2925-2020

Terminated Class II Medical devices

Recall started
16 July 2020
Terminated
27 July 2021
Reason
Incorrect manufacturer calibration
Distribution
USA: CA, TX, RI OUS: Armenia; Australia; Brazil; Bulgaria; Canada; Finland; France; Germany; Hong Kong; India; Israel; Italy; Japan; Mongolia; Morocco; Spain
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2793-2020, Z-2792-2020

Terminated Class II Medical devices

Recall started
25 September 2019
Terminated
25 March 2024
Reason
The Brainlab Patient Data Manager software (PDM) in combination with the Brainlab iPlan CMF/Cranial/ENT/Spine software 2.1.1, 2.2.0, 2.2.1, 2.3.0, 2.3.1, 2.4.0, 2.5.0, 2.5.1 (if used in combination with iPlan CMF/Cranial/ENT/Spine 3.0.5, 3.0.6) that may lead to shifts applied to segmentation objects in iPlan being not reflected when exported into DICOM under specific circumstances.
Distribution
worldwide
Initiated
Voluntary: Firm initiated
Recall number
Z-0176-2020

Terminated Class II Medical devices

Recall started
11 March 2019
Terminated
12 May 2021
Reason
There is a potential for an incorrect dose distribution calculation by Brainlab RT Elements software (for affected versions) under specific circumstances when using the Pencil Beam algorithm on the GPU (graphics card), as is the default system setting.
Distribution
Worldwide Distribution - US Nationwide in the states of AL, AR, AZ, CA, CO, CT, FL, GA, IA, ID, IN, KY, LA, MA, MD, MS, NC, NJ, NY, OH, OR, PA, SC, TN, TX, UT, VA, & WV. Algeria, Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Colombia, El Salvador, Finland, France, Germany, Hong Kon
Initiated
Voluntary: Firm initiated
Recall number
Z-1205-2019

Terminated Class I Medical devices

Recall started
27 February 2019
Terminated
10 July 2019
Reason
In certain occurrences, the affected navigation software application might unexpectedly display a navigated instrument in an axial, coronal/sagittal (ACS) view representation with fixed planes in the image reconstruction (the not-updated ACS view ), instead of displaying the desirable view representation Inline View , which is commonly used for navigating invasive instruments at the spine. This could lead the surgeon to be unable to determine the position of the navigated instrument. This might occur after a crash restore or after changing between different navigation workflows during the same patient treatment.
Distribution
Worldwide Distribution: US (Nationwide) and countries of: Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Ecuador, France, Germany, Greece, Hong Kong, Ireland, Italy, Japan, Kazakhstan, Malaysia, New Zealand, Philippines, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand and
Initiated
Voluntary: Firm initiated
Recall number
Z-1082-2019

Terminated Class II Medical devices

Recall started
14 February 2018
Terminated
17 May 2021
Reason
The usage of workflows that deviate from the recommended specifications in the User manual for ExacTrac Patient Positioning System (versions 6.0, 6.1, 6.2, 6.5) with Auxiliary Device Interface (ADI) and Varian Clinac or Varian TrueBeam, which may result in misinterpretation of beam authorization via ADI.
Distribution
worldwide
Initiated
Voluntary: Firm initiated
Recall number
Z-1006-2018

Terminated Class II Medical devices

Recall started
16 November 2017
Terminated
24 August 2020
Reason
Due to a human error at a supplier, an unknown number of devices within one specific production lot of Brainlab DrapeLink Adapters (Left/Right) were not manufactured according to defined specifications.
Distribution
Distributed in the US to Kansas. Distributed internationally to Australia, Finland, France, Germany, Hong Kong, Ireland, Japan, Netherlands, Norway, Sweden, Switzerland, Taiwan, Turkey, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall number
Z-0320-2018

Terminated Class II Medical devices

Recall started
28 July 2017
Terminated
25 July 2018
Reason
Risk of unintended motion while the AIRO system is in transport mode.
Distribution
Worldwide Distribution - US Nationwide in the U.S. States: of AK, AZ, CA, CO, FL, GA, IL, KY, LA, MD, MA, MI, MN, MT, MO, NJ, NY, NC, OH, PA, RI, TN, TX, UT, VA, WA, and WV; and the countries of Argentina, Australia, Austria, Belgium, Canada, Egypt, France, Germany, India, Italy, Japan, Kazakhstan,
Initiated
Voluntary: Firm initiated
Recall number
Z-0509-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.